Abstract
The surgical treatment of liver metastases from carcinoid tumors is burdened by a relatively poor symptomatic relief and a high mortality rate. Temporary liver dearterialization, separating the operative trauma from the temporary hepatic occlusion, may have advantages. We have utilized this treatment in 16 patients. The effect of treatment was registered in symptomatic relief, changes in urinary 5-HIAA, serotonin in platelet-poor plasma, and morphologic changes shown by angiography.
Fourteen patients, who underwent only the dearterialization procedure, survived the immediate postoperative period, while 2 patients who had concomitant small bowel resection both died of complications, 1 and 3 months postoperatively, respectively. One patient died, 14 months postoperatively, of the carcinoid disease. All but 1 patient were free from symptoms for at least 6 months. Two patients have had no recurrence of the carcinoid syndrome for 34 and 42 months, respectively. A decrease in urinary 5-HIAA was seen after 6 months in 10 patients, serotonin declined in 7 patients, and angiography showed regression in 7 patients. The results of this study indicate that temporary liver dearterialization is a safe procedure with low mortality and good symptomatic relief from the carcinoid syndrome.
Résumé
Le traitement chirurgical des métastases hépatiques des tumeurs carcinoÏdes n'entraÎne qu'une amélioration peu importante des manifestations symptomatiques. Il reste grevé d'une importante mortalité. La désartérélisation temporaire du foie pourrait en revanche présenter quelques avantages. Nous l' avons tentée chez 16 malades. L'effet du traitement fut jugé en fonction de l'amélioration des phénomènes symptomatiques, des modifications du taux des 5-HIAA urinaires, du taux de la sérotinine dans le plasma et des modifications morphologiques à l'angiographie.
14 patients qui ont été soumis à ce procédé thérapeutique ont survécus à l'opération, alors que 2 sont morts; le premier un mois et le second trois mois après l'opération qui avait comporté la résection de l'intestin. Sur les 14 survivants, un est mort 14 mois après l'opération de la généralisation du processus tumoral, 13 opérés n'ont présenté aucun symptome du moins pendant 6 mois, 2 n'ont présenté de récidive qu' après 34 et 42 mois respectivement. Une diminution dans le taux des 5-HIAA urinaires après 6 mois fut constatée chez 10 malades. Le taux de sérotinine s'abaissa chez 7 d'entre eux, cependant que l'angiographie montrait une régression des lésions chez également 7 de ces malades.
Les résultats de cette étude montrent que la désartérélisation temporaire du foie représente un procédé thérapeutique valable car la mortalité opératoire est faible et les symptomes dûs à l'origine carcinoÏde du processus tumoral régressent nettement.
Similar content being viewed by others
References
Segall, H.N.: An experimental anatomical investigation of the blood and bile channels of the liver. Surg. Gynecol. Obstet.37:152, 1923
Bierman, H.R., Byron, R.L., Jr., Kelley, K.H., Grady, A.: Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. J. Natl. Cancer Inst.12:107, 1951
Breedis, C., Young, G.: The blood supply of neoplasms in the liver. Am. J. Pathol.30:969, 1954
Ackerman, N.B., Lien, W.M., Kondi, E.S., Silverman, N.A.: The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to “small” and “large” tumors. Surgery66:1067, 1969
Nilsson, L.A.V., Zettergren, L.: Blood supply and vascular pattern of induced primary hepatic carcinoma in rats. Acta Pathol. Microbiol. Scand.71:179, 1967
Markowitz, J.: The hepatic artery. Surg. Gynecol. Obstet.95:644, 1952
Koudahl, G., Funding, J.: Hepatic artery ligation in primary and secondary hepatic cancer. Acta Chir. Scand.138:289, 1972
Bengmark, S., Rosengren, K.: Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am. J. Surg.119:620, 1970
Michels, N.A.: Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the coeliac axis. Cancer6:708, 1953
Bengmark, S., Fredlund, P., Hafström, L., Vang, J.: Present experiences with hepatic dearterialization in liver neoplasm. Prog. Surg.13:141, 1974
Bengmark, S., Fredlund, P.: Palliative treatment of primary and secondary malignant liver neoplasms. In Liver Surgery, R.Y. Calne and Q. della Rovere, editors, Piccin editore,in press
Almersjö, O., Bengmark, S., Rudenstam, C.M., Hafström, L., Nilsson, L.A.V.: Evaluation of hepatic dearterialization in primary and secondary cancer of the liver. Am. J. Surg.124:5, 1972
Fortner, J.G., Mulcare, R.J., Solis, A., Watson, R.C., Golbey, R.B.: Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann. Surg.178:162, 1973
Murray-Lyon, I.M., Dawson, J.L., Parsons, V.A., Rake, M.O., Blendis, L.M., Laws, J.W., Williams, R.: Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs.
Bengmark, S., Fredlund, P.: Temporary dearterialization combined with intra-arterial infusion of oncolytic drugs in the treatment of liver tumours. Prog. Clin. Cancer7:207, 1978
Berjian, R.A., Douglass, H.O., Jr., Nava, H.R., Karakousis, C.: The role of hepatic artery ligation and dearterialization with infusion chemotherapy in advanced malignancies in the liver. J. Surg. Oncol.14:379, 1980
Edelmann, G., Boutelier, P., de Montalier, H.: Traitment des métastases carcinoidiennes par ligature de l'artère hépatique. Chirurgie104:300, 1978
Farndon, J.R.: The carcinoid syndrome: Methods of treatment and recent experience with hepatic artery ligation and infusion. Clin. Oncol.3:365, 1977
Nobin, A., Karp, W., Lunderquist, A., Rosengren, E., Sanden, G., Sundler, F.: Localization of carcinoids and pheochromocytomas with vein catheterization and amine determination. Brain Res. Bull.in press
Macfarlane, P.S., Dalgliesh, C.E., Dutton, R.W., Lennox, B., Nyhus, L.M., Smith, A.N.: Endocrine aspects of argentaffinoma with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis. Scot. Med. J.1:148, 1956
Tilson, M.D.: Carcinoid syndrome. Surg. Clin. North Am.54:409, 1974
Battersby, C., Egerton, W.S.: A carcinoid saga. Austr. N.Z. J. Surg.44:32, 1974
Davis, Z., Moertel, C.G., McIhath, D.C.: The malignant carcinoid syndrome. Surg. Gynecol. Obstet.137:637, 1973
Stephen, J.L., Graham-Smith, D.G.: Treatment of the carcinoid syndrome by local removal of hepatic metastases. Proc. R. Soc. Med.65:444, 1972
Wilson, H., Butterick, O.D.: Massive liver resection for control of severe vasomotor reactions secondary to malignant carcinoid. Ann. Surg.149:641, 1959
Aune, S., Schistad, G.: Carcinoid liver metastases treated with hepatic dearterialization. Am. J. Surg.123:715, 1972
McDermott, W.V., Jr., Paris, A.L., Clouse, M.E., Meissner, W.A.: Dearterialization of the liver for metastatic cancer. Ann. Surg.187:38, 1978
Idema, A.A.J., Niermeyer, P., Oldhoff, J.: Hepatic dearterialization for carcinoid syndrome due to liver metastases. Arch. Chir. Neerl.29:125, 1977
Törnebrandt, K., Nobin, A., Ericsson, M., Thomson, D.: Circulation, respiration and serotonin levels in carcinoid patients during anesthesia. Anaesthesiain press
Nagasue, N., Inokuchi, K., Kobayashi, M., Ogawa, Y., Iwaki, A., Yukaya, H.: Hepatic dearterialization for nonresectable primary and secondary tumors of the liver. Cancer38:2593, 1976
Saco, M., Lunderquist, A., Mårtensson, H., Nobin, A., Owman, T.: Angiographic and computed tomographic appearance of secondary carcinoid of the liver. Cardiovasc. Interv. Radiol.in press
Nobin, A., Axelsson, S., Falck, B., Ingemansson, S., Lunderquist, A., Mårtensson, H., Reichardt, W.: Selective mesenteric vein catheterization and plasma serotonin determination in patients with carcinoid tumors. World J. Surg.in press
Feldman, J.M.: Serotonin metabolism in patients with carcinoid tumors: Incidence of 5-hydroxytryptophan-secreting tumors. Gastroenterology75:1109, 1978
Emson, P.C., Gilbert, R.F.T., Mårtensson, H., No-bin, A.: Substance P in plasma as a marker for carcinoid tumors. Lancetin press
Author information
Authors and Affiliations
Additional information
Supported by grants from the Swedish Medical Research Council (grant no. 04X-00712).
Rights and permissions
About this article
Cite this article
Bengmark, S., Ericsson, M., Lunderquist, A. et al. Temporary liver dearterialization in patients with metastatic carcinoid disease. World J. Surg. 6, 46–53 (1982). https://doi.org/10.1007/BF01656372
Issue Date:
DOI: https://doi.org/10.1007/BF01656372